IL160905A0 - Therapeutics and diagnostics for disorders of erythropoiesis - Google Patents

Therapeutics and diagnostics for disorders of erythropoiesis

Info

Publication number
IL160905A0
IL160905A0 IL16090502A IL16090502A IL160905A0 IL 160905 A0 IL160905 A0 IL 160905A0 IL 16090502 A IL16090502 A IL 16090502A IL 16090502 A IL16090502 A IL 16090502A IL 160905 A0 IL160905 A0 IL 160905A0
Authority
IL
Israel
Prior art keywords
erythropoiesis
therapeutics
diagnostics
disorders
Prior art date
Application number
IL16090502A
Other languages
English (en)
Original Assignee
Pfizer Prod Inc
Max Delbruck Ct For Molecular
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc, Max Delbruck Ct For Molecular filed Critical Pfizer Prod Inc
Publication of IL160905A0 publication Critical patent/IL160905A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
IL16090502A 2001-10-31 2002-10-31 Therapeutics and diagnostics for disorders of erythropoiesis IL160905A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US33504801P 2001-10-31 2001-10-31
US33518301P 2001-11-02 2001-11-02
PCT/US2002/034888 WO2003038130A2 (en) 2001-10-31 2002-10-31 Therapeutics and diagnostics for disorders of erythropoiesis

Publications (1)

Publication Number Publication Date
IL160905A0 true IL160905A0 (en) 2004-08-31

Family

ID=26989530

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16090502A IL160905A0 (en) 2001-10-31 2002-10-31 Therapeutics and diagnostics for disorders of erythropoiesis

Country Status (7)

Country Link
US (1) US20040014064A1 (xx)
EP (1) EP1446507A2 (xx)
JP (1) JP2005531280A (xx)
CA (1) CA2460283A1 (xx)
IL (1) IL160905A0 (xx)
MX (1) MXPA04003382A (xx)
WO (1) WO2003038130A2 (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60220621T2 (de) 2001-11-09 2008-03-06 Proteologics, Inc. Posh Nukleinsäure, Polypeptide und darauf bezogene Verfahren
EP1660514A4 (en) * 2003-08-20 2008-04-16 Cleveland Clinic Foundation In NEW GENE AND PROTEIN ASSOCIATED WITH ANGIOGENESIS AND ENDOTHELAPOPTOSIS
DE102004062281A1 (de) * 2003-12-29 2005-07-28 Siemens Ag Verfahren und Spotting-Lösung zum Herstellen von Microarrays
EP1853703B1 (en) 2005-02-25 2011-04-13 Oncotherapy Science, Inc. Peptide vaccines for lung cancers expressing ttk polypeptides
FR2914304B1 (fr) * 2007-03-28 2012-11-16 Guerbet Sa Composes pour le diagnostic de maladies liees a l'expression de vcam.
US8119366B2 (en) * 2007-10-05 2012-02-21 Trojan Technologies, Ltd. Antennapedia-dominant negative mastermind-like construct
US9193973B2 (en) * 2010-12-10 2015-11-24 Alynylam Pharmaceuticals, Inc. Compositions and methods for increasing erythropoietin (EPO) production
JO3623B1 (ar) 2012-05-18 2020-08-27 Amgen Inc البروتينات المرتبطة بمولد المستضاد st2
WO2022221462A1 (en) * 2021-04-13 2022-10-20 Kriya Therapeutics, Inc. Vector constructs for delivery of nucleic acids encoding therapeutic vlcad or mcad and methods of using the same

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5080891A (en) * 1987-08-03 1992-01-14 Ddi Pharmaceuticals, Inc. Conjugates of superoxide dismutase coupled to high molecular weight polyalkylene glycols
US5424186A (en) * 1989-06-07 1995-06-13 Affymax Technologies N.V. Very large scale immobilized polymer synthesis
US5143854A (en) * 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
US5252743A (en) * 1989-11-13 1993-10-12 Affymax Technologies N.V. Spatially-addressable immobilization of anti-ligands on surfaces
US6051380A (en) * 1993-11-01 2000-04-18 Nanogen, Inc. Methods and procedures for molecular biological analysis and diagnostics
US5384261A (en) * 1991-11-22 1995-01-24 Affymax Technologies N.V. Very large scale immobilized polymer synthesis using mechanically directed flow paths
JP3939338B2 (ja) * 1991-11-22 2007-07-04 アフィメトリックス， インコーポレイテッド ポリマー合成に対する組合わせの戦略
US5412087A (en) * 1992-04-24 1995-05-02 Affymax Technologies N.V. Spatially-addressable immobilization of oligonucleotides and other biological polymers on surfaces
US6203897B1 (en) * 1993-09-24 2001-03-20 The Ishizuka Research Institute, Ltd. Sintered composites containing superabrasive particles
US5631734A (en) * 1994-02-10 1997-05-20 Affymetrix, Inc. Method and apparatus for detection of fluorescently labeled materials
US5571639A (en) * 1994-05-24 1996-11-05 Affymax Technologies N.V. Computer-aided engineering system for design of sequence arrays and lithographic masks
US5599695A (en) * 1995-02-27 1997-02-04 Affymetrix, Inc. Printing molecular library arrays using deprotection agents solely in the vapor phase
US5624711A (en) * 1995-04-27 1997-04-29 Affymax Technologies, N.V. Derivatization of solid supports and methods for oligomer synthesis
JP3364230B2 (ja) * 1996-11-14 2003-01-08 アフィメトリックス，インコーポレイテッド パターン化したアレイの合成用の化学増幅
WO1999010535A1 (en) * 1997-08-22 1999-03-04 Yale University A process to study changes in gene expression in stem cells
US6263287B1 (en) * 1998-11-12 2001-07-17 Scios Inc. Systems for the analysis of gene expression data
CA2464845A1 (en) * 1999-08-19 2001-02-22 Curagen Corporation Hematopoietic regulatory factors and methods of use thereof
US6420153B1 (en) * 2000-02-29 2002-07-16 Millennium Pharmaceuticals, Inc. 18232, a novel dual specificity phosphatase and uses therefor
US6436703B1 (en) * 2000-03-31 2002-08-20 Hyseq, Inc. Nucleic acids and polypeptides

Also Published As

Publication number Publication date
WO2003038130A3 (en) 2004-02-12
JP2005531280A (ja) 2005-10-20
CA2460283A1 (en) 2003-05-08
WO2003038130A2 (en) 2003-05-08
EP1446507A2 (en) 2004-08-18
US20040014064A1 (en) 2004-01-22
MXPA04003382A (es) 2004-11-22
WO2003038130A8 (en) 2004-04-22

Similar Documents

Publication Publication Date Title
AU2002344208A8 (en) Molecules for diagnostics and therapeutics
IL157734A0 (en) Pharmaceutical compositions for the treatment of urogenital disorders
AU2002343194A8 (en) System and method for diagnosis of mental disorders
IL159771A0 (en) Combinations for the treatment of inflammatory disorders
GB0007193D0 (en) Treatment of movrmrnt disorders
EP1448205A4 (en) COMBINATIONS FOR THE TREATMENT OF IMMUNO-INFLAMMATORY DISEASES
EP1284723A4 (en) COMPOSITIONS AND METHODS FOR TREATING DISORDERS ASSOCIATED WITH HYPERLIPIDEMIA
HK1041827B (zh) 用於治療雌激素依賴性疾病的化合物以及製備和使用上述化合物的方法
IL160905A0 (en) Therapeutics and diagnostics for disorders of erythropoiesis
WO2003039490A9 (en) Compositions and methods for diagnosing and treating mental disorders
HUP0400296A3 (en) Method for preparation of 10,11-dihydro-10-hydroxy-5h-dibenz/b,f/azepine-5-carboxamide and 10,11-dihydro-10-oxo-5h-dibenz/b,f/azepine-5-carboxamide
IL155874A0 (en) Treatment of anxiety disorders
IL140540A0 (en) Treatment of anxiety disorders
AU2002363139A1 (en) Therapeutics and diagnostics for disorders of erythropoiesis
EP1315499A4 (en) COMPOSITIONS AND METHODS OF TREATING ANORCAL DISEASES
EP1409511A4 (en) DIAGNOSTICS AND THERAPEUTICS FOR AUTOSOMAL-DOMINANT HEMOCHROMATOSIS
HUP0401921A3 (en) Intermediate compounds for the preparation of mirtazapine and the production methods thereof
AU2002348942A8 (en) Process for the preparation of tofisopam and new intermediates
IL157243A0 (en) Preparation of n-methylparoxetine and related intermediate compounds
GB0112075D0 (en) Diagnostic method for osteoporosis and related disorders
AU2002360409A8 (en) Methods and intermediates for the synthesis of azepines
EP1435953A4 (en) ANTI-VESICANS COMPOUNDS AND METHOD FOR THEIR PREPARATION AND USE
TW484380U (en) Separable structure of rail
EP1440167A4 (en) METHODS AND COMPOSITIONS FOR DIAGNOSING AND TREATING HEMATOLOGICAL DISORDERS USING 16319
EP1440166A4 (en) METHODS AND COMPOSITIONS FOR DIAGNOSING AND TREATING HEMATOLOGICAL DISORDERS USING 2777